Stents Lose In Comparisons With Surgery And Medical Therapy

Despite the enormous increase in the use of stents in recent decades, there is little or no good evidence comparing their use to the alternatives of bypass surgery (coronary artery bypass graft, or CABG) or optimal medical therapy in patients also eligible for these strategies. Now two new meta-analyses published in JAMA Internal Medicine provide new evidence that the alternatives to stents (often called a percutaneous coronary intervention, or PCI) remain attractive and that some of the growth in PCI may have been unwarranted. (Stents have been a key element in the growth of several medical device companies, including Medtronic, Boston Scientific, and Abbott.)
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news